Molecular pathogenesis of hepatocellular carcinoma

Altering transforming growth factor-β signaling in hepatocarcinogenesis

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

Hepatocellular carcinoma (HCC) occurs subsequent to liver injury, where regenerative hepatocytes develop into a dysplastic nodule and then early HCC, supporting the multistep hepatocarcinogenesis theory. Molecular alterations such as the p53 mutation, p16 gene silencing, and AKT signaling activation are found in the late stage of HCC progression. The overexpression of some marker molecules is observed at the early stage. Transforming growth factor-β (TGF-β), a potent inhibitor of cell proliferation, is frequently overexpressed in HCC, although the role of TGF-β signaling during HCC development remains controversial. We previously reported that HCC cells show TGF-β receptor-dependent growth inhibition in response to TGF-β. Also, reduced TGF-β receptor II in HCC correlates with intrahepatic metastasis and shorter time-to-recurrence, suggesting a role of TGF-β signaling in tumor suppression. In contrast, TGF-β overexpression in HCC is known to correlate with malignant potential, suggesting a role in tumor promotion. Enhanced formation of stroma is a feature of advanced HCC, and TGF-β also promotes the proliferation of stromal fibroblasts. The microenvironment produced via tumor-stromal interactions may be the key to the modulation of the dual roles of TGF-β signaling in HCC progression.

Original languageEnglish
Pages (from-to)284-288
Number of pages5
JournalDigestive Diseases
Volume29
Issue number3
DOIs
Publication statusPublished - 2011 Aug

Fingerprint

Transforming Growth Factors
Hepatocellular Carcinoma
Growth Factor Receptors
p16 Genes
Neoplasms
Gene Silencing
Hepatocytes
Fibroblasts
Cell Proliferation
Neoplasm Metastasis
Recurrence
Mutation
Liver
Wounds and Injuries

Keywords

  • Hepatocellular carcinoma
  • Hepatocyte growth factor
  • Microenvironment
  • Multistep carcinogenesis
  • TGF-β signaling
  • Tumor-stromal interaction

ASJC Scopus subject areas

  • Gastroenterology

Cite this

@article{22cb83135ff34661b90e1529d2a07da3,
title = "Molecular pathogenesis of hepatocellular carcinoma: Altering transforming growth factor-β signaling in hepatocarcinogenesis",
abstract = "Hepatocellular carcinoma (HCC) occurs subsequent to liver injury, where regenerative hepatocytes develop into a dysplastic nodule and then early HCC, supporting the multistep hepatocarcinogenesis theory. Molecular alterations such as the p53 mutation, p16 gene silencing, and AKT signaling activation are found in the late stage of HCC progression. The overexpression of some marker molecules is observed at the early stage. Transforming growth factor-β (TGF-β), a potent inhibitor of cell proliferation, is frequently overexpressed in HCC, although the role of TGF-β signaling during HCC development remains controversial. We previously reported that HCC cells show TGF-β receptor-dependent growth inhibition in response to TGF-β. Also, reduced TGF-β receptor II in HCC correlates with intrahepatic metastasis and shorter time-to-recurrence, suggesting a role of TGF-β signaling in tumor suppression. In contrast, TGF-β overexpression in HCC is known to correlate with malignant potential, suggesting a role in tumor promotion. Enhanced formation of stroma is a feature of advanced HCC, and TGF-β also promotes the proliferation of stromal fibroblasts. The microenvironment produced via tumor-stromal interactions may be the key to the modulation of the dual roles of TGF-β signaling in HCC progression.",
keywords = "Hepatocellular carcinoma, Hepatocyte growth factor, Microenvironment, Multistep carcinogenesis, TGF-β signaling, Tumor-stromal interaction",
author = "Ken Yamazaki and Yohei Masugi and Michiie Sakamoto",
year = "2011",
month = "8",
doi = "10.1159/000327560",
language = "English",
volume = "29",
pages = "284--288",
journal = "Digestive Diseases",
issn = "0257-2753",
publisher = "S. Karger AG",
number = "3",

}

TY - JOUR

T1 - Molecular pathogenesis of hepatocellular carcinoma

T2 - Altering transforming growth factor-β signaling in hepatocarcinogenesis

AU - Yamazaki, Ken

AU - Masugi, Yohei

AU - Sakamoto, Michiie

PY - 2011/8

Y1 - 2011/8

N2 - Hepatocellular carcinoma (HCC) occurs subsequent to liver injury, where regenerative hepatocytes develop into a dysplastic nodule and then early HCC, supporting the multistep hepatocarcinogenesis theory. Molecular alterations such as the p53 mutation, p16 gene silencing, and AKT signaling activation are found in the late stage of HCC progression. The overexpression of some marker molecules is observed at the early stage. Transforming growth factor-β (TGF-β), a potent inhibitor of cell proliferation, is frequently overexpressed in HCC, although the role of TGF-β signaling during HCC development remains controversial. We previously reported that HCC cells show TGF-β receptor-dependent growth inhibition in response to TGF-β. Also, reduced TGF-β receptor II in HCC correlates with intrahepatic metastasis and shorter time-to-recurrence, suggesting a role of TGF-β signaling in tumor suppression. In contrast, TGF-β overexpression in HCC is known to correlate with malignant potential, suggesting a role in tumor promotion. Enhanced formation of stroma is a feature of advanced HCC, and TGF-β also promotes the proliferation of stromal fibroblasts. The microenvironment produced via tumor-stromal interactions may be the key to the modulation of the dual roles of TGF-β signaling in HCC progression.

AB - Hepatocellular carcinoma (HCC) occurs subsequent to liver injury, where regenerative hepatocytes develop into a dysplastic nodule and then early HCC, supporting the multistep hepatocarcinogenesis theory. Molecular alterations such as the p53 mutation, p16 gene silencing, and AKT signaling activation are found in the late stage of HCC progression. The overexpression of some marker molecules is observed at the early stage. Transforming growth factor-β (TGF-β), a potent inhibitor of cell proliferation, is frequently overexpressed in HCC, although the role of TGF-β signaling during HCC development remains controversial. We previously reported that HCC cells show TGF-β receptor-dependent growth inhibition in response to TGF-β. Also, reduced TGF-β receptor II in HCC correlates with intrahepatic metastasis and shorter time-to-recurrence, suggesting a role of TGF-β signaling in tumor suppression. In contrast, TGF-β overexpression in HCC is known to correlate with malignant potential, suggesting a role in tumor promotion. Enhanced formation of stroma is a feature of advanced HCC, and TGF-β also promotes the proliferation of stromal fibroblasts. The microenvironment produced via tumor-stromal interactions may be the key to the modulation of the dual roles of TGF-β signaling in HCC progression.

KW - Hepatocellular carcinoma

KW - Hepatocyte growth factor

KW - Microenvironment

KW - Multistep carcinogenesis

KW - TGF-β signaling

KW - Tumor-stromal interaction

UR - http://www.scopus.com/inward/record.url?scp=80051768100&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051768100&partnerID=8YFLogxK

U2 - 10.1159/000327560

DO - 10.1159/000327560

M3 - Article

VL - 29

SP - 284

EP - 288

JO - Digestive Diseases

JF - Digestive Diseases

SN - 0257-2753

IS - 3

ER -